Literature DB >> 3872030

Ceruletide intravenous dose-response study by a simplified scintigraphic technique.

G T Krishnamurthy, F E Turner, D Mangham, V V Bobba, S A White, K Langrell.   

Abstract

The intravenous dose response of a ceruletide diethylamine (ceruletide) was established by a simplified scintigraphic technique where multiple graded doses were given sequentially on a single occasion. The gallbladder volume was represented nongeometrically by 99mTc-IDA counts. The mean latent period, ejection period, and ejection rate were similar for all four groups of subjects given 1-20 ng/kg of ceruletide. The mean (+/- SD) ejection fractions after 1, 5, 10, and 15 ng/kg of ceruletide as the single dose were 19.4 +/- 11.9%, 59.6 +/- 26.0%, 55.2 +/- 23.3%, and 67.8 +/- 8.7%, respectively. These ejection fractions were similar to the values when the identical dose of ceruletide was administered sequentially either before or after another dose. A dose of 5 ng/kg produced the most physiologic type of emptying. Intravenous doses of 10 ng/kg and larger caused adverse reactions in 42% of the total doses in the form of abdominal pain, nausea, systolic and diastolic hypotension, or bradycardia. It is concluded that the dose response of a cholecystokininlike agent (ceruletide) can be established reliably by a scintigraphic technique where multiple graded doses are given on a single occasion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872030     DOI: 10.2214/ajr.144.4.733

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man.

Authors:  V Garrigues; J Ponce; C Cano; R Sopena; M Hoyos; A Del Val; J Berenguer
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Use of Entero-Test, a simple approach for non-invasive clinical evaluation of the biliary disposition of drugs.

Authors:  William J Guiney; Claire Beaumont; Steve R Thomas; Darren C Robertson; Simon M McHugh; Annelize Koch; Duncan Richards
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

3.  A requiem for the cholecystokinin provocation test?

Authors:  A Smythe; A W Majeed; M Fitzhenry; A G Johnson
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients.

Authors:  A A Masclee; J B Jansen; W M Driessen; L M Geuskens; C B Lamers
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

5.  Gallbladder response to a second dose of cholecystokinin during the same imaging study.

Authors:  S Sostre; M I Canto; A N Kalloo
Journal:  Eur J Nucl Med       Date:  1992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.